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Abstract
Red blood cell (RBC) traits provide insight into a wide range of physiological states and exhibit
moderate to high heritability, making them excellent candidates for genetic studies to inform
underlying biologic mechanisms. Previous RBC trait genome-wide association studies were per-
formed primarily in European- or Asian-ancestry populations, missing opportunities to inform
understanding of RBC genetic architecture in diverse populations and reduce intervals surrounding
putative functional SNPs through fine-mapping. Here, we report the first fine-mapping of 6 corre-
lated (Pearson’s r range: |0.04-0.92|) RBC traits in up to 19 036 African Americans and 19 562
Hispanic/Latino participants of the Population Architecture using Genomics and Epidemiology con-
sortium. Trans-ethnic meta-analysis of race/ethnic- and study-specific estimates for approximately
11 000 SNPs flanking 13 previously identified association signals as well as 150 000 additional
array-wide SNPs was performed using inverse-variance meta-analysis after adjusting for study and
clinical covariates. Approximately half of previously reported index SNP-RBC trait associations
generalized to the trans-ethnic study population (p<1.7 3 1024); previously unreported inde-
pendent association signals within the ABO region reinforce the potential for multiple functional
variants affecting the same locus. Trans-ethnic fine-mapping did not reveal additional signals at the
HFE locus independent of the known functional variants. Finally, we identified a potential novel
association in the Hispanic/Latino study population at the HECTD4/RPL6 locus for RBC count
(p51.9 3 1027). The identification of a previously unknown association, generalization of a large
proportion of known association signals, and refinement of known association signals all exemplify
the benefits of genetic studies in diverse populations.
1 | INTRODUCTION
Red blood cell (RBC) trait measurements are used to characterize the
physiology of RBCs in both clinical and research settings, are cap-
tured by a complete blood count panel, and include the primary
traits hematocrit (HCT), hemoglobin (HGB), and RBC count. Accom-
panying HCT, HGB, and RBC count are 3 derived traits—mean cor-
puscular hemoglobin (MCH), MCH concentration (MCHC), and mean
corpuscular volume (MCV)—which can be used in combination with
primary traits to evaluate RBC development and maintenance.
Together, primary and derived RBC trait deficiencies (e.g., abnormally
low HGB or excessive RBC count) cause circulatory diseases such as
thalassemia, polycythemia, and genetic or nonhereditary anemias.1–5
Population-specific HBB causal alleles for recessive diseases such as
sickle-cell anemia and b-thalassemia have also been associated with
protection against malaria and myocardial infarction, respectively, in
the heterozygous state.6–8 Additionally, RBC traits have been associ-
ated with stroke, cardiovascular disease (CVD) in populations with
chronic kidney disease, and all-cause mortality.9–12 RBC traits are
therefore of substantial public health and clinical importance, yet
their underlying pathophysiological mechanisms remain incompletely
characterized.
As RBC traits exhibit moderate to high heritability (40%-90%),
population-based genetic analysis of these phenotypes can help iden-
tify causal alleles for and inform the underlying biology of RBC-related
disorders.3,13,14 To date, over 80 independent association signals with
one or more RBC traits have been reported, primarily in studies of
European- or Asian-ancestry populations.15–24 One genome-wide asso-
ciation study (GWAS) performed in over 16 000 African Americans
identified 12 genome-wide-significant loci previously reported in
European-ancestry or Japanese populations, indicating a shared role for
common variants at RBC trait association signals.16 However, fine-
mapping of RBC trait associations identified in GWAS has had limited
success narrowing broad GWAS signals to prioritize functional candi-
dates because of large linkage disequilibrium (LD) blocks or characteriz-
ing variants that are rare or monomorphic in Europeans or Asians, as
has been demonstrated for platelet count.25,26 Narrowing and fine-
mapping of previously identified association signals may be improved
by performing analyses in ancestrally diverse populations with multi-
continental admixture, including African Americans and Hispanics/
Latinos.16,17,27
Here, we evaluated 32 index SNP-RBC trait associations in 11
fine-mapped Metabochip regions, previously identified in populations
of European-, Japanese-, and South Asian descent (SPTA1, BCL11A,
HFE, ABO, HK1, SH2B3/ATXN2, LIPC, PPCDC, NUTF2, NEUROD2, and
TMPRSS6) for evidence of generalization and locus refinement in Afri-
can American and Hispanic/Latino participants of the Population Archi-
tecture using Genomics and Epidemiology (PAGE) consortium.28
Additionally, we evaluated all SNPs genotyped on the Metabochip for
associations not previously described in any of the 6 RBC traits. These
efforts will help address gaps in understanding the genetic underpin-
nings of RBC traits.
2 | MATERIALS AND METHODS
2.1 | Study populations
The PAGE consortium is a National Human Genome Research Institute
funded effort to examine the epidemiologic architecture of genetic var-
iants associated with human diseases and traits across diverse popula-
tions.29 The following PAGE I studies contributed to this manuscript
(Supplemental Materials and Methods): the Atherosclerosis Risk in
Communities Study (ARIC),30 the Coronary Artery Risk Disease in
Young Adults study (CARDIA),31 the Cardiovascular Health Study
(CHS),32 the Hispanic Community Health Study/Study of Latinos
(HCHS/SOL),33 and the Women’s Health Initiative (WHI).34 The Icahn
Mt. Sinai School of Medicine (MSSM) contributed both African Ameri-
can and Hispanic/Latino study populations separately from PAGE I.29
The Institutional Review Board at all participating institutions approved
the study protocol and all participants gave written consent.
2.2 | Genotype platforms
The Metabochip was a custom Illumina iSELECT array that contained
approximately 195 000 SNPs and was designed to support large scale
follow-up of putative associations for cardiovascular and metabolic
traits.28 Further information on genotyping and quality control is pro-
vided in the supplemental material. We defined an index SNP as a SNP
reported in the GWAS catalog prior to October 1, 2016, as having a
genome-wide significant association (5 3 1028) with at least one of
the 6 RBC traits we evaluated. Index SNPs that were not directly geno-
typed on the Metabochip were represented by proxies, defined as
SNPs in high LD (r20.80) with the GWAS index SNP in the ancestral
population in which the association was first reported. For one index
SNP, rs671 (ALDH2), no proxy was available because this variant is spe-
cific to populations of East Asian ancestry. A total of 74% of partici-
pants were directly genotyped on the Illumina custom Metabochip
array; genotypes for the remaining participants were imputed from the
Affymetrix 6.0 panel.35 After QC and study-population-specific effec-
tive heterozygosity criteria were applied, 163 929 SNPs were available
for analysis in African Americans and 159 467 SNPs were available for
analysis in Hispanics/Latinos.
2.3 | Statistical analysis
We performed 4 types of analysis: (1) generalization, whereby we
examined 32 index SNP associations across 6 RBC traits; (2) fine-
mapping of association signals that generalized in (1); (3) testing for
independent association signals for any RBC trait within one of the 11
densely genotyped regions; and (4) discovery of previously unreported
associations with any RBC trait in all remaining Metabochip regions.
Only SNPs meeting an effective heterozygosity of 35 were used within
each race/ethnic study population; 4814 SNPs were excluded in His-
panics/Latinos but included for African Americans, whereas 9431 were
excluded for African Americans but included for Hispanics/Latinos. We
examined a maximum of 8082 SNPs in African Americans and 7991
SNPs in Hispanics/Latinos (9201 SNPs total) within one of 11 regions
densely genotyped on the Illumina Metabochip for all nondiscovery
analyses.
To interpret fine-mapping results, LD was calculated in 500 kb slid-
ing windows using PLINK (http://pngu.mgh.harvard.edu/purcell/plink)
and African American (ARIC data), Hispanic/Latino (HCHS/SOL data),
and trans-ethnic panels (randomly sampled ARIC and HCHS/SOL par-
ticipant data in proportion to the racial/ethnic-specific sample popula-
tion sizes).36 In addition, Metabochip LD and frequency information
(but not individual-level information) was provided by the Malm€o Diet
and Cancer Study on 2143 control participants from a Swedish popula-
tion to facilitate LD and MAF comparisons between PAGE African
American and Hispanic/Latino populations and populations of Euro-
pean ancestry.37 We used NCBI build 36 positions for regional associa-
tion plots. Recombination rates were estimated from the combined
HapMap phase II data.
A weighted version of generalized estimating equations (GEE;
HCHS/SOL) accommodating the HCHS/SOL sampling design, related-
ness, and household structure was implemented in SUGEN.38 Race/
ethnic-stratified linear regression was performed for all other studies
(Atherosclerosis Risk in Communities [ARIC], Coronary Artery Risk
Development in Young Adults [CARDIA], Cardiovascular Health Study
[CHS], Icahn Mt. Sinai School of Medicine BioMe Biobank [MSSM],
and WHI) using PLINK.36 We evaluate the association between each
quantitative RBC trait (see Supplement for RBC trait measurement
methods and calculations for derived equations, Supporting Informa-
tion Table S2) and a maximum of 9201 SNPs (racial/ethnic- and study-
specific effective heterozygosity >35, present in more than one study
in either African Americans or Hispanics/Latinos) from 11 previously
identified RBC trait loci. An additive genetic model was assumed
including age, sex, study center/region, and 10 ancestry principal com-
ponents. Racial/ethnic-stratified and trans-ethnic study-specific associ-
ation results were combined via inverse variance meta-analysis as
implemented in METAL.39 Genomic inflation factors were not calcu-
lated as the design of the Metabochip purposefully emphasizes poten-
tial functional candidates, leading to expected early departure from a
uniform p-value distribution.
2.4 | Generalization
We defined an “association signal” as a set of SNPs genotyped in a
Metabochip fine-mapped region and exhibiting linkage disequilibrium
(r20.2 in the Malm€o Diet and Cancer Study) with a previously
reported genome-wide significant SNP for one or more RBC traits. For
2 or more previously reported genome-wide-significant SNPs to be
considered within the same association signal in our study, those var-
iants had to be in LD.
We next defined an “index SNP” as the most significant previously
reported SNP within an association signal for each RBC trait. In instan-
ces for which multiple SNPs were published as the most significant
SNP within a particular association signal for the same trait, we
selected the SNP with the lowest reported p-value as the index SNP.
The index SNP within an association signal may vary by trait because
of differences in sample size, measurement error, and allelic
heterogeneity among other possible reasons related to genetic archi-
tecture of the traits. Therefore, we evaluated the most significant SNP
reported for each association signal-trait combination rather than
selecting one index SNP to evaluate in all traits for which that associa-
tion signal was previously reported as genome-wide-significant, even
though some of the index SNPs likely tag the same genetic association
across multiple RBC traits. For example, the SH2B3/ATXN2 association
signal has been reported for multiple RBC traits with the most signifi-
cant SNP differing by trait, meaning the index SNP for RBC count is
rs3184504 whereas the index SNP for hematocrit is rs11065987.
These 2 SNPs are in LD and likely represent the same association sig-
nal. Furthermore, while several RBC trait associations examined in this
article were first reported in Japanese populations, those associations
have since been generalized to European populations. European LD
blocks are typically larger than for African or admixed-ancestry haplo-
types, therefore we used European LD to conservatively define loci
when analyzing potential independent associations in fine-mapped
regions containing previously reported RBC trait GWAS associations.
We then evaluated whether association signals identified in popu-
lations of European, Japanese, or South Asian ancestry generalized to
African American and Hispanic/Latino populations. Approximately 44%
of all previously reported genome-wide-significant RBC trait SNPs, but
only 13% of reported association signals (defined above based on Euro-
pean LD, identified as of September 2016), were located in fine-
mapped regions on the Metabochip.15–24 The generalization signifi-
cance criterion was then defined as a51.7 3 1024, a Bonferroni-
corrected threshold calculated using 294 tag SNPs in African Ameri-
cans (r2 0.80; determined using African American LD from the ARIC
Study) that captured all SNPs correlated with the index SNPs repre-
senting 32 index SNP-trait associations as identified in the Malm€o Diet
Study population.
2.5 | Fine-mapping generalized associations
We evaluated association-signal narrowing across ancestral back-
grounds by comparing the number of SNPs in high LD with the trans-
ethnic lead SNP, as well as the width of the region covered by the
high-LD SNPs (Table 2, Figure 1 and Supporting Information Figure
S2). LD for African Americans was calculated using ARIC study partici-
pants; LD for Hispanics/Latinos was calculated using HCHS/SOL study
participants.
2.6 | Independent and discovery SNP identification
To identify independent SNPs influencing RBC traits, we identified all
SNPs at the 11 RBC trait loci that were uncorrelated with the index
SNPs (r2<0.20 in the Malm€o Diet and Cancer Study). Sequential con-
ditional analyses were then performed by adjusting for significant
racial/ethnic-specific lead SNPs. If a statistically significant association
was identified, defined as 0.05 divided by the number of SNPs in Afri-
can Americans with MAF0.01 that were uncorrelated with the index
SNPs (n58907; a55.61 3 1026), the SNP was identified as inde-
pendent and added to the adjustment set. Sequential conditional
analysis was repeated until no significant SNPs were identified. We
evaluated all remaining SNPs for discovery in African Americans or His-
panics/Latinos using a Metabochip-wide significant threshold of 0.05/
155 022 (the number of SNPs available for evaluation after exclusion
of SNPs evaluated for generalization), or a53.23 3 1027, and only
considered SNPs with an effective heterozygosity >30 in more than
one cohort study population per race/ethnicity.
2.7 | Bioinformatic characterization of RBC trait loci
For each of the significant RBC trait SNPs (i.e., any lead SNP that gen-
eralized in one or both race/ethnic populations or the trans-ethnic
meta-analysis; or any novel SNP identified in either race/ethnic popula-
tion), all SNPs in LD (r20.8) were identified in the appropriate 1000
Genomes reference superpopulations (AFR [Africans] for African Amer-
icans and AMR [Admixed Americans] for Hispanics/Latinos) for func-
tional annotation. Using HaploRegV2,40 all variants in each LD block
were characterized with putative functional roles including: conserva-
tion; promoter and/or enhancer epigenetic markers, derived from the
Roadmap Epigenomics Project41 and ENCODE42; DNAse hypersensi-
tive sites; and transcription factor binding motifs calculated as a library
of position weight matrices.43–45 Evidence of functional activity consid-
ered promoter and enhancer regions based on histone modification
patterns in k562 erythroleukemia cells in the Roadmap Epigenome Pro-
ject; DNase hypersensitive sites in ENCODE tissues including erythro-
blasts and erythroid leukemia cell lines; and transcription factor binding
evidence in k562 erythroid leukemia cells. Evidence of cis-eQTL status
was performed using Blueprint for relevant blood tissues.46 All func-
tional elements that varied by cell type were restricted to RBC-relevant
tissues (Supporting Information Tables S12a, S12b).
In order to evaluate the relevance of trans-ethnic PAGE lead SNPs
across tissue types, we compared the eQTL status of index SNPs in
both blood-relevant and other tissues (Supporting Information Table
S13). We looked up significant eQTLs for each index SNP (p<1E-06)
in whole blood in GTEx, which provides data on a wide array of tissues;
and 2 blood-specific eQTL databases: the blood eQTL browser; and
the NESDA NTR Conditional eQTL catalog.47–49 Only GTEx tissues
which showed an association with at least one SNP are reported. We
further reported clinical relevance of the trans-ethnic lead SNPs as
described in the literature.50,51
3 | RESULTS
We analyzed 6 correlated RBC traits (Pearson’s correlation coefficient
range: 20.29 to 0.92 in Hispanic Community Health Study/Study of
Latinos (HCHS/SOL) participants; Supporting Information Tables S1,
S2) in a maximum of 19 036 African American and 19 562 Hispanic/
Latino participants from 6 studies participating in the PAGE consortium
(Supporting Information Table S3). Females were over-represented
among both African Americans (83%) and Hispanic/Latinos (70%). The
HCHS/SOL (n511 675) and Women’s Health Initiative (WHI,
n517 363, of which 12 022 are African American) studies contributed
the largest proportion of Hispanic/Latino (60%) and African American
(63%) participants, respectively.
FIGURE 1 A, HGB association signal at ABO(1) generalizes to Hispanics/Latinos but not African Americans. B, HGB association signal at
ABO(2) generalizes to African Americans but not Hispanics/Latinos Locus-Zoom plots representing (L-R) African American, Hispanic/Latino,
and trans-ethnic meta-analysis SNP-HGB associations on respective African American, Hispanic/Latino, and trans-ethnic LD backgrounds,
respectively. X-axis represents increasing chromosomal position on chromosome 9; left y-axis represents –log10 p-value of each association;
right y-axis represents the calculated recombination rate at each chromosomal location. Correlation of each SNP to the index SNP (purple
diamond) are indicated by color as shown in the r-squared values in the box on the upper left of the left-most Locus-Zoom plots [Color figure
can be viewed at wileyonlinelibrary.com]
4 .
3.1 | Generalization and fine-mapping of 11 densely
genotyped metabochip regions
3.1.1 | Generalization
First, we examined 11 regions densely genotyped on the Illumina
Metabochip and harboring one or more variants previously associated
at genome-wide significance (p<5 3 1028) with at least one RBC trait
(Supporting Information Table S4). All but 2 of the 11 regions con-
tained one association signal, with the HFE and ABO regions each con-
taining 2 association signals (see Methods). Of these 13 association
signals, 8 were previously associated with 2 or more RBC traits and 2
were previously associated with 4 traits, for a total of 32 index SNP-
trait associations (Table 1, Supporting Information Tables S5, S6).
Seventeen of the 32 index SNP-trait associations (53%) general-
ized at p<1.7 3 1024 to the trans-ethnic study population (Table 1,
Supporting Information Tables S7, S8), of which 6 trans-ethnic lead
SNPs were identical to the previously reported index SNP. Of the
remaining 11 generalized associations, 9 trans-ethnic lead SNP p-values
exceeded the index SNP p-values by at least an order of magnitude
(Table 1, Supporting Information Table S10). Effect sizes for both gen-
eralized and nongeneralized association signals for index SNPs and
trans-ethnic lead SNPs were consistent with previously reported esti-
mates (Supporting Information Table S6).17
The first HFE association signal (index SNP: rs198846) generalized
with the same trans-ethnic lead SNP (rs1799945, the functional H63D
hemochromatosis variant) to all 3 previously reported traits—HGB,
MCH, and MCV. Furthermore, both ABO association signals (Figure 1)
and the SH2B3/ATXN2 association signal generalized to all traits except
RBC count. Notably, RBC count was the only trait for which none of
the index SNP generalized in the trans-ethnic population; it also was
the trait with the smallest sample size (46% of the maximum number of
participants). Association signals for SPTA1, BCL11A, LIPC, NUTF2,
PPCDC, and NEUROD2 did not generalize. Six nongeneralized index
SNP-trait associations could not be evaluated for directional consis-
tency because a proxy SNP was used in generalization analyses or the
effect size was not reported in the initial publication (Supporting Infor-
mation Table S9). For the remaining 8 nongeneralized index SNP-trait
associations with sufficient information to evaluate directional consis-
tency, 6 were directionally consistent in the trans-ethnic population.
Additionally, when compared to SNP-trait associations from a previ-
ously published RBC trait GWAS, 7 of 11 PAGE lead SNPs exceeded
the generalization significance threshold in 24 167 participants of the
CHARGE consortium (Supporting Information Table S14).17
In race/ethnicity-specific meta-analyses (Table 2, Supporting Infor-
mation Tables S6-S8), 9% (n53) of index SNP-trait associations gener-
alized to African Americans and generalization was limited to HGB.
Conversely, 38% (n512) of index SNP-trait associations generalized to
Hispanics/Latinos, including the SH2B3/ATXN2 association with RBC
count, representing the only instance where evidence of generalization
for the RBC trait was detected. Of note, HCT, HGB, and MCHC were
reported for similar numbers of Hispanics/Latino and African American
participants in our study population, whereas MCH, MCV, and RBC
count were reported for more than twice as many Hispanics/Latinos as
African Americans, potentially contributing to the disparity in general-
ization by race/ethnicity.
3.1.2 | Novel independent signals in 11 fine-mapped
regions
We next evaluated the 11 fine-mapped regions to identify significant
variants independent of published association signals by examining all
SNPs that were uncorrelated with any of the index SNPs (see Meth-
ods). We identified no independent associations in previously reported
regions for any of the 6 RBC traits (significance threshold: p<1.3 3
1025).
3.1.3 | Fine-mapping
To fine-map association signals that generalized, we then evaluated the
LD structure in the trans-ethnic study population and by race/ethnicity
(Figure 1 and Supporting Information FigureS2, Table 2). The median
reduction in interval width was 75%, likely because of the large reduc-
tion in association signals for which the index variant was functional
but fell within a large LD block in Europeans. The first HFE association
signal showed consistent evidence of narrowing across 3 traits (113 kb
decrement), with the same trans-ethnic lead SNP for all traits (the
causal H63D variant rs1799945, CAF50.97 in African Americans,
CAF50.88 in Hispanics/Latinos). Both ABO association signals (the lat-
ter of which has the determining variant for blood type B, rs8176746,
as the published index SNP) fine-mapped to a limited number of SNPs
in narrow LD blocks in the trans-ethnic study population, with the
trans-ethnic lead SNP varying by trait. Rs855791 is a known functional
coding variant in TMPRSS6, therefore we do not consider this signal to
be narrowed.
3.1.4 | Discovery
Next, all SNPs outside the 11 previously identified RBC trait-associated
regions were evaluated for evidence of discovery associations (p<3.03
3 1027, see Methods). No SNP association exceeded Metabochip-
wide significance in the total trans-ethnic study population or among
African Americans for any RBC trait. However, one previously unre-
ported association met Metabochip-wide significance in Hispanics/Lat-
inos: rs76350043 at HECTD4/RPL6 (chr 12q24.13, p52.5 3 1027) for
RBC count (Supporting Information Table S11). This SNP was also
nominally significant for HCT and HGB (p<0.05).
3.1.5 In silico bioinformatics analysis
All SNPs highly correlated (r20.9 in relevant AFR or AMR 1000
Genomes Phase I ancestral populations) with trans-ethnic lead SNPs
from generalization analysis were examined using publicly available
functional prediction data for erythrocytes or erythroblastoid cell lines,
as well as pathogenicity prediction (Supporting Information Tables
S12a, S12b).52 With the exception of the well-established TMPRSS6
missense variant rs855791 (generalized to HCT, HGB, MCH, MCHC,
and MCV), all trans-ethnic lead variants and their LD proxies were non-
coding variants. Lead SNPs and their LD proxies most commonly exhib-
ited potential regulatory effects including disruption of RBC-relevant












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































activity. Several SNPs at generalized loci exhibited promise for molecu-
lar characterization, including rs198851, the HCT lead SNP in His-
panics/Latinos at the first HFE association signal. In k562 erythroid
leukemia cells, rs198851 exhibits both DNase and enhancer activity, is
an eQTL for TRIM38, and is located within an RNA Polymerase II ChIP-
seq peak. With the exception of one association signal (TMPRSS6 in
both African Americans and Hispanics/Latinos), all independent signals
contained at least one SNP with evidence for a regulatory function or
cis-eQTL activity in relevant blood cell types (Supporting Information
Tables S12a, S12b).
We also evaluated tissue specificity of significant eQTLs (p<1E-
06) for each published index SNP or trans-ethnic lead SNP for all gen-
eralized association signals, as well as the putative clinical relevance of
each SNP when information was available (Supporting Information
Table S13).47–51 EQTL results show varied evidence of tissue expres-
sion effects. Lead or index variants for SH2B3/ATXN2 and TMPRSS6
fine-mapped regions demonstrated no significant association with any
gene expression in any tissue type. In contrast, SNPs within the second
ABO association signal showed evidence of broad ABO expression
across 30 tissue types. SNPs in the first ABO association signal show
evidence of expression for multiple genes, but across fewer tissues
than the second signal. Lead and index SNPs within the second HFE
association signal were only associated with expression of genes other
than HFE across a broad array of GTEx tissues; no lead or index SNPs
for the second HFE association signal exhibited eQTL activity for the
HFE gene in any tissue type. The first HFE association signal showed
some evidence of tissue specificity in gene expression profiles—both
the index SNP and trans-ethnic lead SNP exhibited cis-eQTLs for either
HFE or several other genes—but overlap by tissue type was uncommon
in this association signal.
4 | DISCUSSION
In this study we performed generalization, fine-mapping, and discovery
analysis of 6 RBC traits in a population of over 38 000 African Ameri-
can and Hispanic/Latino PAGE participants. We demonstrated that
genetic regions influencing RBC traits identified in European- and
Asian-ancestry populations are also applicable to African American and
Hispanic/Latino populations. The merits of incorporating multi-ethnic
study populations in genomic studies were also displayed via locus
refinement and identification of a previously unreported RBC trait
association that warrants validation in future studies.
In the 11 fine-mapped regions we evaluated, over half of known
index SNP-trait associations generalized to the trans-ethnic study pop-
ulation across all 6 RBC traits, indicating that the effects of known RBC
loci are likely shared across ancestral populations. Additionally, 10 of
17 generalized associations (59%) met or exceeded the more stringent
genome-wide significance threshold of 5 3 1028 in the trans-ethnic
study population. Although some association signals showed variation
in lead SNP, the trans-ethnic lead SNPs almost always matched across
traits when we restricted to participants with all traits measured
(results not shown). The higher proportion of generalized associations
in Hispanics/Latinos compared to African Americans suggests that
results in Hispanic/Latino populations may contribute disproportion-
ately to the larger trans-ethnic findings. This was not surprising given
the Metabochip design that was enriched for European ancestral con-
tent as well as Hispanic/Latino genetic architecture, which shares more
features with European-ancestry or Asian-ancestry individuals than
does African American architecture.53 Additionally, the SNPs desig-
nated as proxies for index SNPs discovered in European- or Japanese-
ancestry individuals were almost always in much lower LD in African
Americans than Hispanics/Latinos, suggesting that previously reported
index SNPs are not highly effective for characterizing the genetic archi-
tecture of RBC traits in African Americans.
We also detected several instances where trans-ethnic lead SNPs
showed considerably stronger evidence of association with RBC traits
in our study population than previously reported GWAS index SNPs
identified in primarily European or East Asian populations. By examin-
ing visualizations of generalized association signals, we further identi-
fied several cases in which the lead SNP in LD with the European index
SNP was not the most significant SNP in the region, indicated differen-
ces in genetic architecture by ancestry. These findings are consistent
with recent work in large trans-ethnic populations, which demonstrated
considerable effect heterogeneity by genetic ancestry in GWAS index
SNPs reported in studies of predominantly European populations; con-
siderably less evidence of heterogeneity was detected when examining
index SNPs identified in multi-ethnic populations.54 Of particular rele-
vance are recent demonstrations of inappropriate designation of var-
iants which are rare in European populations as pathogenic when they
are in fact common in other ancestral groups.55 GWAS inclusive of
diverse populations can improve the accuracy of identifying functional
variants, but fine-mapping is particularly well suited to this type of
exercise. In the era of precision medicine, as interest in genetic risk
scores for RBC traits increases for conditions such as pregnancy, cardi-
ovascular and neurological diseases, and mortality, studies examining
generalization of reported loci to global populations will become even
more important.22,56–59
Over the past decade, GWAS have identified hundreds of loci
associated with RBC traits, but these findings incompletely account for
the population-level variability attributable to additive genetic effects.
A possible explanation for this missing heritability is that all genes
expressed within RBC-relevant tissues play a role in RBC trait biology,
but their identification would require near-infinite statistical power.60 A
recent review described the suite of genes affecting complex traits as
including both “core” genes (i.e., those with tissue-specific effects cru-
cial to one or few complex traits) and “peripheral” genes (i.e., those
with broad expression profiles playing a role in many traits).61 Distin-
guishing core from peripheral genes may inform canonical pathways
for RBC traits, provide mechanistic insight into biology, and inform tar-
gets for pharmaceutical intervention.60,61 Importantly, this designation
occurs on a spectrum, with some genes not clearly predisposed to one
class over the other. For example, hexokinase 1 (HK1) is highly and
ubiquitously expressed, and several GWAS have identified associations
within 200 kb of HK1 for psychiatric phenotypes, autoimmune disor-
ders, and blood metabolite levels.17,62 However, HK1 was also the only
generalized association signal in our study with evidence of a blood-
specific eQTL, which localized to a narrow segment of intron 4 repre-
senting GWAS study populations of multiple ancestries. The approxi-
mately 10 kb segment contains multiple regulatory elements (e.g.,
DNase hypersensitivity regions and histone methylation marks), but
GWAS findings to-date for this region remain restricted to RBC traits,
and RBC trait index SNPs within 500 kb of this region remain restricted
to this narrow genomic fragment. These results reinforce the concept
that tissue-specific regulators may play an important role for individual
complex traits in broadly expressed genes. In light of this information
and other complex-trait GWAS findings, tissue-specific expression data
and genomic information will be particularly relevant when considering
candidate variants for functional studies.
Large-scale genetic evaluation of correlated traits is challenging,
particularly when evaluating multiple populations and traits with vari-
able sample sizes. Importantly, novel statistical methods scalable to
GWAS that leverage correlation among phenotypes for novel locus dis-
covery have been reported.56–59,63 Such approaches seem particularly
well suited for RBC traits, given evidence of a shared genetic architec-
ture and the number of GWAS associations which have been reported
in multiple RBC traits.17,22 Regarding fine-mapping, extensions of
correlated-phenotype methods were recently described and have simi-
larly shown promise for reducing sets of SNPs for functional evaluation
over single-trait methods. However, no studies to date have leveraged
such innovations for discovery or fine-mapping of RBC traits.
Finally, we identified a potential novel association at the HECTD4/
RPL6 locus for RBC count. The HECTD4/RPL6 locus has been previ-
ously associated with MCV (which exhibits modest correlation with
RBC count and HGB), blood pressure, coronary heart disease, and mul-
tiple metabolic traits.64–68 Additionally, coding mutations within several
members of the ribosomal protein gene family have been causally asso-
ciated with Diamond-Blackfan anemia, making an association with RBC
count plausible.69,70 This association signal fell within a sparsely geno-
typed region on the Metabochip, and hence could not be further eval-
uated via fine-mapping. Evidence of association with multiple non-RBC
traits should motivate larger efforts to understand whether the mecha-
nisms underlying these associations are shared across traits or whether,
for instance, tissue-specific effects relevant to each trait are repre-
sented by the same signal. Multi-ethnic fine-mapping to narrow the
association signal for molecular characterization likely represents an
ideal first-step, as functional variants in this region have not been
described for other associated traits.
This study faced several limitations which deserve consideration.
First, phenotype availability differed by study and smaller sample sizes
for MCH, MCV, and RBC count likely reduced power, specifically
among the African American study population. Second, 5 of 11 fine-
mapped regions we evaluated (SPTA1, BCL11A, HK1, LIPC, and
TMPRSS6) also were mapped narrowly (<100 kb) with few SNPs,
potentially providing insufficient coverage of African American or His-
panic/Latino genetic content to perform comprehensive fine-mapping
and generalization analyses. Sparse coverage in the SPTA1 and BCL11A
regions could also contribute to lack of generalization at these loci, at
which the respective genes have established, functional roles in RBC
development and maintenance.71–73 With regard to bioinformatic char-
acterization for functional candidate SNP evaluation, eQTL analysis—
while insufficient as the sole determinant of tissue specificity—is an
important component for ascertaining functional status of candidate
variants. Finally, the Metabochip design emphasized regions identified
for cardiometabolic traits, so overlap with RBC-trait associations was
coincidental; we therefore could not examine generalization or fine-
mapping in several well established RBC trait associations, including
HBS1L/MYB, LUC7L/ITGF3, HBA1/2, and HBB.17,18,21,74
5 | CONCLUSION
Population-based GWAS emphasize discovery, and are often the first
step toward elucidating the genetic architecture underlying complex
quantitative traits like RBC traits. Fine-mapping previously reported
associations—particularly associations identified in genetically homoge-
neous populations, including European- and East Asian-ancestry popu-
lations—provides additional information about known association
signals and can lead to narrowing of broad association signals to reduce
the burden for bioinformatics and molecular functional analysis. Addi-
tional characterization of genetic associations contributing to
population-level variability of RBC traits through large-scale sequencing
and methods exploiting the correlation of RBC traits may further illumi-
nate biological pathways for these complex quantitative traits.
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